机译:患有阶段IV子宫癌癌的妇女的生存结果接受新辅助化疗,然后进行手术
Division of Gynecologic OncologyUniversity of Southern CaliforniaLos Angeles California;
Division of Gynecologic OncologyUniversity of KentuckyLexington Kentucky;
The Gynecologic Oncology CenterMercy Medical CenterBaltimore Maryland;
Division of Gynecologic OncologyUniversity of PittsburghPittsburgh Pennsylvania;
Division of Gynecologic OncologyUniversity of South FloridaTampa Florida;
Department of Breast and Medical OncologyNational Cancer Center HospitalTokyo Japan;
Division of Gynecologic OncologyUniversity of Southern CaliforniaLos Angeles California;
Department of Obstetrics and GynecologyTohoku UniversityMiyagi Japan;
Division of Gynecologic Oncology Department of Obstetrics and Gynecology Albert Einstein College;
Department of Obstetrics and GynecologySaitama Medical University International Medical;
Department of Obstetrics and GynecologyOsaka UniversityOsaka Japan;
Department of Obstetrics and GynecologyTokai UniversityKanagawa Japan;
Department of Obstetrics and GynecologyKyoto UniversityKyoto Japan;
Department of Obstetrics and GynecologyTottori UniversityTottori Japan;
Department of Obstetrics and GynecologyOsaka Rosai HospitalOsaka Japan;
Division of Gynecologic OncologyUniversity of Southern CaliforniaLos Angeles California;
Department of Obstetrics and GynecologyThe University of TokyoTokyo Japan;
Department of Obstetrics and GynecologyNiigata UniversityNiigata Japan;
Department of Obstetrics and GynecologyKawasaki Medical SchoolOkayama Japan;
Department of Obstetrics and GynecologyAichi Medical UniversityAichi Japan;
Department of Obstetrics and GynecologyKurashiki Medical CenterOkayama Japan;
Department of Obstetrics and GynecologyIwate Medical UniversityMorioka Japan;
Department of Obstetrics and GynecologyTokushima UniversityTokushima Japan;
Department of Obstetrics and GynecologyKitano HospitalOsaka Japan;
Department of GynecologyShizuoka Cancer CenterShizuoka Japan;
Division of Gynecologic OncologyUniversity of South FloridaTampa Florida;
Division of Gynecologic Oncology Department of Obstetrics and GynecologyOregon Health &
Science;
Department of GynecologyCancer Institute HospitalTokyo Japan;
The Gynecologic Oncology CenterMercy Medical CenterBaltimore Maryland;
Division of Gynecologic OncologyUniversity of KentuckyLexington Kentucky;
Division of Gynecologic OncologyUniversity of Southern CaliforniaLos Angeles California;
carboplatin; neoadjuvant chemotherapy; paclitaxel; stage IV; survival outcome; uterine carcinosarcoma;
机译:患有阶段IV子宫癌癌的妇女的生存结果接受新辅助化疗,然后进行手术
机译:根据体格检查标准,广泛的细胞减灭术和选择性新辅助化疗后的生存结果在庞大的IIIC和IV期上皮性卵巢癌中
机译:回顾性评估完全切除I-IV期子宫癌肉瘤的化学疗法和仅放疗的辅助治疗的结果。
机译:可变形图像配准作为改善乳腺癌新辅助化疗后生存预测的工具:ACRIN 6657 / I-SPY-1试验的结果
机译:阶段T4B头部和颈部癌症生存结果比较基于治疗方式:手术是可行的治疗选项吗?
机译:根据体格检查标准广泛的细胞减灭术和选择性新辅助化疗后的生存结果在庞大的IIIC和IV期上皮性卵巢癌中
机译:原发性减瘤手术加化学疗法或新辅助化疗后间隔减瘤手术后,IIIC期至IV期上皮性卵巢癌完全缓解的复发模式和临床结局:意大利多中心回顾性研究